Taysha Gene Therapies (TSHA) Debt Ratio: 2022-2025
Historic Debt Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to 0.16.
- Taysha Gene Therapies' Debt Ratio fell 32.63% to 0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year decrease of 32.63%. This contributed to the annual value of 0.27 for FY2024, which is 16.84% up from last year.
- According to the latest figures from Q3 2025, Taysha Gene Therapies' Debt Ratio is 0.16, which was up 30.44% from 0.12 recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Debt Ratio registered a high of 0.91 during Q3 2023, and its lowest value of 0.12 during Q2 2025.
- Over the past 3 years, Taysha Gene Therapies' median Debt Ratio value was 0.26 (recorded in 2024), while the average stood at 0.32.
- Its Debt Ratio has fluctuated over the past 5 years, first surged by 169.95% in 2023, then slumped by 73.93% in 2024.
- Taysha Gene Therapies' Debt Ratio (Quarterly) stood at 0.30 in 2022, then declined by 22.00% to 0.23 in 2023, then increased by 16.84% to 0.27 in 2024, then slumped by 32.63% to 0.16 in 2025.
- Its Debt Ratio was 0.16 in Q3 2025, compared to 0.12 in Q2 2025 and 0.31 in Q1 2025.